| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8794184 | Ophthalmology | 2018 | 7 Pages |
Abstract
Visual loss is common in subjects with PIC, predominantly secondary to late development of CNVM. Treatment with oral corticosteroids may help to reduce the risk of CNVM development, and anti-VEGF therapy for CNVM was associated with better clinical outcomes.
Keywords
CNVMSVLFFAPICIQRMVLBCVAlogMARfundus fluorescein angiographybest-corrected visual acuitychoroidal neovascular membraneconfidence intervalVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)logarithm of the minimum angle of resolutioninterquartile rangehazard ratiopunctate inner choroidopathy
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Rachael L. MBChB, PhD, Rose BSc, MRCOphth, Sue L. PhD, FRCOphth, Oren MD, PhD,